Paraoxonase in Oxidation and Inflammation
A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Antioxidant Enzyme Systems".
Deadline for manuscript submissions: closed (31 August 2019) | Viewed by 18988
Special Issue Editor
Interests: oxidative stress; inflammation; metabolism; non-communicable diseases; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Since the existence of an enzyme termed paraoxonase was first described, more than 30 years ago, the number of publications describing its biological function and the role that it plays in human biology has increased exponentially. Currently, the existence of three different phylogenetically-related paraoxonases has been reported. All three are lipolactonases that degrade lipid peroxides within the cells and in the circulation. Because of this, the three enzymes play important roles as antioxidants and protect against oxidative stress and the consequent inflammatory reaction. Paraoxonases and their alterations have been related to diseases as important as cardiovascular diseases, obesity, liver diseases, neurological disorders, infectious diseases and cancer. Paraoxonases also seem to play a role in protecting mitochondrial function and the normal functioning of energy metabolism, and are a part of the innate immune system. This Special Issue aims to publish original research papers and reviews on paraoxonases and their relationships with oxidative stress and inflammation and wishes to be an instrument for communication and dissemination of the most recent findings about the role that these enzymes play in human diseases.
Dr. Jordi Camps
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Infectious diseases
- Inflammation
- Non-communicable diseases
- Paraoxonases
- Oxidative stress
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.